{"title":"Integrated Transcriptomics and Machine Learning Reveal Lipid Metabolism Related Genes in Ischemic Stroke","authors":"Qiu-Lin Wang, Chang-Le Fang, Tian-Hao Bao, Rui-Ze Niu","doi":"10.1007/s12031-026-02519-8","DOIUrl":null,"url":null,"abstract":"<div>\n \n <p>Lipid metabolism dysregulation is considered a key metabolic feature of ischemic stroke (IS) and may also contribute to its related neuropsychiatric complications. However, its critical regulatory molecules remain unclear. By integrating machine learning methods with transcriptomic analyses, this study systematically characterized the molecular networks underlying lipid metabolism in IS. Using bulk RNA-seq data obtained from the middle cerebral artery occlusion model, we observed a significant increase in lipid metabolic activity. By combining differential gene expression analysis, Weighted Gene Co-expression Network Analysis, and machine learning algorithms, we ultimately identified Hmox1, Stat3, and Tlr2 as core genes associated with lipid metabolism dysregulation. Functional enrichment analysis highlighted the strong association between these genes and lipid metabolism pathways. Further single-cell transcriptomic analyses emphasized the significant role of MG in the lipid metabolism disorder of IS. Furthermore, differential gene expression, functional enrichment analysis, and virtual knockout indicated that Hmox1, Stat3 and Tlr2 in microglia were closely related to lipid metabolic activity. In summary, this study identified Hmox1, Stat3, and Tlr2 as potential regulatory targets for microglial lipid metabolism in IS, providing a novel theoretical foundation for understanding the IS mechanism and its potential neuropsychiatric complications and for developing targeted intervention.</p>\n </div>","PeriodicalId":652,"journal":{"name":"Journal of Molecular Neuroscience","volume":"76 2","pages":""},"PeriodicalIF":2.7000,"publicationDate":"2026-04-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Molecular Neuroscience","FirstCategoryId":"3","ListUrlMain":"https://link.springer.com/article/10.1007/s12031-026-02519-8","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"BIOCHEMISTRY & MOLECULAR BIOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Lipid metabolism dysregulation is considered a key metabolic feature of ischemic stroke (IS) and may also contribute to its related neuropsychiatric complications. However, its critical regulatory molecules remain unclear. By integrating machine learning methods with transcriptomic analyses, this study systematically characterized the molecular networks underlying lipid metabolism in IS. Using bulk RNA-seq data obtained from the middle cerebral artery occlusion model, we observed a significant increase in lipid metabolic activity. By combining differential gene expression analysis, Weighted Gene Co-expression Network Analysis, and machine learning algorithms, we ultimately identified Hmox1, Stat3, and Tlr2 as core genes associated with lipid metabolism dysregulation. Functional enrichment analysis highlighted the strong association between these genes and lipid metabolism pathways. Further single-cell transcriptomic analyses emphasized the significant role of MG in the lipid metabolism disorder of IS. Furthermore, differential gene expression, functional enrichment analysis, and virtual knockout indicated that Hmox1, Stat3 and Tlr2 in microglia were closely related to lipid metabolic activity. In summary, this study identified Hmox1, Stat3, and Tlr2 as potential regulatory targets for microglial lipid metabolism in IS, providing a novel theoretical foundation for understanding the IS mechanism and its potential neuropsychiatric complications and for developing targeted intervention.
期刊介绍:
The Journal of Molecular Neuroscience is committed to the rapid publication of original findings that increase our understanding of the molecular structure, function, and development of the nervous system. The criteria for acceptance of manuscripts will be scientific excellence, originality, and relevance to the field of molecular neuroscience. Manuscripts with clinical relevance are especially encouraged since the journal seeks to provide a means for accelerating the progression of basic research findings toward clinical utilization. All experiments described in the Journal of Molecular Neuroscience that involve the use of animal or human subjects must have been approved by the appropriate institutional review committee and conform to accepted ethical standards.